Cathie Wood Crispr Therapeutics Ag Transaction History
Ark Investment Management LLC
- $12.1 Billion
- Q2 2025
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ark Investment Management LLC holds 10,182,590 shares of CRSP stock, worth $576 Million. This represents 4.09% of its overall portfolio holdings.
Number of Shares
10,182,590
Previous 10,165,400
0.17%
Holding current value
$576 Million
Previous $346 Million
43.17%
% of portfolio
4.09%
Previous 3.73%
Shares
33 transactions
Others Institutions Holding CRSP
# of Institutions
525Shares Held
69.6MCall Options Held
3.72MPut Options Held
2.33M-
Capital International Investors Los Angeles, CA5.59MShares$317 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$208 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$185 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$161 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$157 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.42B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....